Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Raymond James Financial (RJF)

Raymond James Financial (RJF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Zacks.com featured highlights include The Walt Disney, Leidos, Raymond James Financial, Fortinet and The Hartford Financial Services

For Immediate ReleaseChicago, IL – December 31, 2024 – Stocks in this week’s article are The Walt Disney Company DIS, Leidos Holdings, Inc. LDOS, Raymond James Financial, Inc. RJF, Fortinet, Inc....

HIG : 109.17 (-0.21%)
DIS : 111.85 (+0.45%)
RJF : 155.33 (unch)
LDOS : 144.85 (+0.55%)
5 High ROE Stocks to Buy With Markets Likely to Wrap Up on a High

The broader U.S. equity markets have witnessed significant volatility over the past few trading days as concerns regarding the Federal Reserve’s interest rate cuts took center stage amid stubborn inflation....

FTNT : 95.96 (+1.57%)
HIG : 109.17 (-0.21%)
DIS : 111.85 (+0.45%)
RJF : 155.33 (unch)
LDOS : 144.85 (+0.55%)
VERSABANK ANNOUNCES EXERCISE OF OVER-ALLOTMENT OPTION IN PUBLIC OFFERING

/CNW/ - VersaBank (Nasdaq: VBNK) (TSX: VBNK) (the "Bank") today announced that the underwriters of its previously announced public offering of common shares...

VBNK : 13.85 (+2.90%)
VBNK.TO : 19.74 (+1.49%)
RJF : 155.33 (unch)
Global M&A to Improve in 2025: 3 Investment Bank Stocks to Consider

The pace of global mergers and acquisitions (M&A) activity gained momentum this year, and there are signs that deal-making will accelerate in 2025. A favorable interest rate environment, strong economic...

BCS : 13.15 (-1.05%)
MS : 127.45 (+1.37%)
GS : 579.60 (+1.22%)
RJF : 155.33 (unch)
BLUE MOON METALS CLOSES C$30 MILLION IN EQUITY FINANCING WITH LEAD ORDERS FROM HARTREE PARTNERS, WHEATON PRECIOUS METALS AND LNS, AND SIGNS DEFINITIVE AGREEMENTS TO ACQUIRE TWO NORWEGIAN BROWNFIELD COPPER PROJECTS

/CNW/ - Blue Moon Metals Inc. ("Blue Moon" or the "Company") (TSXV: MOON), Nussir ASA ("Nussir") and Nye Sulitjelma Gruver AS ("NSG") are pleased to announce...

MOON.VN : 0.355 (+1.43%)
RJF : 155.33 (unch)
Raymond James Financial Stock: Is RJF Outperforming the Financial Sector?

Although Raymond James Financial has outperformed relative to the financial sector over the past year, Wall Street analysts maintain a cautiously optimistic outlook on the stock’s prospects.

XLF : 48.67 (+0.70%)
SF : 106.88 (+0.75%)
RJF : 155.33 (unch)
VERSABANK COMPLETES SUCCESSFUL OFFERING OF COMMON SHARES

/CNW/ - VersaBank (NASDAQ: VBNK) (TSX: VBNK) (the "Bank") today announced that it has successfully completed its previously announced public offering of common...

VBNK : 13.85 (+2.90%)
VBNK.TO : 19.74 (+1.49%)
RJF : 155.33 (unch)
Insider Sale: President of $RJF (RJF) Sells 10,000 Shares

Tashtego S Elwyn, the President of $RJF ($RJF), sold 10,000 shares of the company on 12-13-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 23.4% of their...

RJF : 155.33 (unch)
VERSABANK PRICES OFFERING OF COMMON SHARES

/CNW/ - VersaBank (Nasdaq:VBNK; TSX:VBNK) (the "Bank") today announced the pricing of its previously announced public offering of 5,660,378 common shares (the...

VBNK : 13.85 (+2.90%)
VBNK.TO : 19.74 (+1.49%)
RJF : 155.33 (unch)
Goldman Sachs Gets Regulatory Approval for Fund Sales in China

The Goldman Sachs Group, Inc. GS has obtained regulatory approvals from the Beijing Bureau of China Securities Regulatory Commission to sell funds in China. This was first reported by Reuters.The license...

BAC : 44.26 (+0.71%)
MS : 127.45 (+1.37%)
GS : 579.60 (+1.22%)
RJF : 155.33 (unch)

Barchart Exclusives

Tarsus Pharmaceutical - Eye Care Therapeutics
Summary Tarsus Pharmaceuticals (TARS) has shown strong technical indicators, including a 48.35% gain since the Trend Seeker buy signal on 9/4 and 173.43% gain in the last year. The company focuses on novel eye care therapeutics, with its lead product XDEMVY targeting blepharitis caused by Demodex mites and other promising... Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar